Mid-market biotech Target a small to mid-sized biotech contractor or research group seeking scalable lab products or services, given AKERS BIOSCIENCES INC operates with a lean team and revenue in the lower end of the spectrum. Focus on cost-efficient, modular solutions they can deploy quickly.

Growth opportunities With revenue in the 1M-10M range and a recent growth trajectory likely, position value-added lab services, contract research, or consumables that improve throughput and reduce time to result to support expansion plans.

Customization potential Emphasize flexible, customizable assay or kit development, as a smaller firm may seek tailored solutions to differentiate in biotechnology research and development without committing to large enterprise contracts.

Affordability focus Highlight cost-conscious offerings, scalable pricing, and favorable total cost of ownership to appeal to a company with modest revenue but ambitious R&D programs.

Partnership readiness Position AKERS as a potential partner for co-development, distribution, or regional sales support in the U.S. market, leveraging their NJ location to align with regional logistics and regulatory considerations.